6-((TERT-BUTOXYCARBONYL)(METHYL)AMINO)-5-CHLORONICOTINIC ACID, 95.0%, 250mg

5-Amino-1-(4-ethoxy-phenyl)-1H-pyrazole-4-carbonitrile, 95.0%, 1g

(S)-2-(2-(((9H-FLUOREN-9-YL)METHOXY)CARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL)ACETIC ACID, 95%, 1g

2,4-Dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde, 97.0%, 250mg

3-(4-Bromophenyl)-1H-[1,2,4]triazole, 95.0%, 5g

1-Methyl-3-n-octylimidazolium Bis(trifluoromethanesulfonyl)imide>97.0%(HPLC)5g

(5-Methylbenzo[b]thiophen-2-yl)boronic acid, 97%, 5g

6-Chloro-2-hydrazinylbenzo[d]thiazole, 95.0%, 1g

1-(2,6-DICHLOROPHENYL)CYCLOBUTANEMETHANAMINE, 95%, 250mg

1-Chloro-6-methylisoquinoline, 95.0%, 1g

5,6-DICHLORO-1H-INDAZOLE-3-CARBONITRILE, 97%, 50mg

Filtres pour seringues Minisart® NML avec marquage CE stérile (stérilisé à l'EtO), 0,2 µm, Luer Lock mâle, 50 pièce(s)

4-Fluoro-2-iodobenzonitrile, 98.0%, 5g